
Unfortunately, the recording of this session was incomplete so we share with you instead our summary of the conversation.
Leveraging advanced partnering data
- Echo Zhang VP of Product Strategy @ Inpart
- Rana Houry Product Manager @ Inpart
- Sofia Petta Consultant @ Evaluate Pharma
This session focused on establishing best practices for using data to enhance partnering operations. It highlighted the value of advanced partnering data, automation, and third-party integration, and explored how to balance information with intuition for smarter decision-making.
HIGHLIGHTS
- Echo Zhang - Data as a Foundation for AI
- Introducing Inpart Deal
- Streamlining data entry
- Reducing data entry errors
- Reporting and strategic insights
- Leveraging Evaluate Data for partnering
Key themes and talking points
Echo Zhang, VP of Product Strategy @ Inpart
Data as a Foundation for AI
Echo highlighted how crucial it is to have good, organized, and actionable data as a foundation for leveraging AI. She emphasized that while AI can deliver powerful insights, it’s only as good as the data feeding it.
Introducing Inpart Deal
Echo introduced Inpart Deal, a product launched two years ago, now adopted by over 50 companies. She explained that Inpart Deal supports users throughout the partnering process, from search and evaluation to alliance management and due diligence. The product focuses on making it easier to input data through automated integrations with tools like Evaluate Pharma and other partnering platforms.
Streamlining Data Entry
Echo discussed the challenges of manual data entry and shared how Inpart Deal addresses this by enabling automatic data uploads from various sources, like partnering conference platforms and email communications. The goal is to reduce the burden on business development teams, allowing them to focus more on high-value tasks.
Collaboration and Data Sharing
Another key focus was collaboration within organizations. Echo explained that Inpart Deal allows different teams to engage in the data entry process, improving the overall quality and consistency of data while reducing duplicates.
Data Integrity and Compliance
Ensuring that data is compliant and up to date was emphasized as a top priority. Echo noted that Inpart Deal helps maintain data integrity, allowing companies to confidently generate reports and make data-driven decisions.
Rana Houry, Product Manager @ Inpart
Reducing Data Entry Errors
Rana elaborated on the importance of reducing manual data entry errors and ensuring uniformity. She showcased how Inpart Deal allows users to autofill data by selecting existing company profiles or pulling information from Evaluate Pharma, thus avoiding typos and ensuring standardized classifications.
Evaluating Opportunities with Integrated Data
She highlighted the seamless integration of external data from Evaluate Pharma directly into the platform. This integration helps teams make informed decisions without needing to leave the system, ensuring that both internal and external data are accessible during evaluations.
Upcoming Features for Enhanced Data Management
Rana teased upcoming features, such as integrating more data sources and providing reminders or alerts about updates to specific opportunities. These features aim to improve decision-making by ensuring teams have the most up-to-date information.
Reporting and Strategic Insights
She discussed the importance of accurate data for generating reliable reports, whether for individual performance tracking or strategic decision-making. With well-organized data, companies can evaluate gaps in their strategy and adjust accordingly.
Sofia Petta, Consultant @ Evaluate Pharma
Leveraging Evaluate Data for Partnering
Sofia introduced the broad capabilities of Evaluate Pharma, emphasizing its extensive coverage of drugs, trials, and company profiles. This data is crucial for BD teams when evaluating assets or potential partners.
Integrated Data for Streamlined Partnering
She discussed how Evaluate Pharma data will soon be fully integrated into the Inpart Deal platform, providing real-time updates on assets, companies, and market trends. This integration aims to support more accurate and efficient decision-making within the Inpart platform.
Driving Objective Decision-Making
Sofia highlighted how Evaluate’s consulting team can assist with prioritizing assets, identifying licensing partners, and providing strategic analysis. The aim is to use the comprehensive data available to help companies make more objective, informed partnering decisions.